Personal information

Other IDs

SciProfiles: 1215786
Scopus Author ID: 57203880723

Activities

Collapse all

Employment (1)

Hospital Universitario de la Princesa: Madrid, Spain, ES

2018-02-01 to present | Researcher (Farmacología)
Employment
Source: Self-asserted source
Pablo Zubiaur

Education and qualifications (3)

Universidad Autónoma de Madrid: Madrid, Madrid, ES

2017-10-22 to 2020-12-18 | PhD in Pharmacology and Physiology (Pharmacology)
Qualification
Source: Self-asserted source
Pablo Zubiaur

Universidad CEU San Pablo: Madrid, Madrid, ES

2011-09-01 to 2017-06-01 | BSc Biotechnology
Education
Source: Self-asserted source
Pablo Zubiaur

Universidad CEU San Pablo: Madrid, Madrid, ES

2011-09-01 to 2016-06-01 | BSc/MPharm Pharmacy
Education
Source: Self-asserted source
Pablo Zubiaur

Professional activities (3)

The Pharmacogene Variation Consortium (PharmVAR): Kansas City, US

2022-06-01 to present
Membership
Source: Self-asserted source
Pablo Zubiaur

Clinical Pharmacogenetics Implementation Consortium: Madrid, ES

2020-01-01 to present
Membership
Source: Self-asserted source
Pablo Zubiaur

Sociedad Española de Farmacogenética y Farmacogenómica: Madrid, SS

2018-01-01 to present
Membership
Source: Self-asserted source
Pablo Zubiaur

Funding (7)

IDENTIFICACIÓN DE FACTORES CLÍNICOS Y FARMACOGENÉTICOS PREDICTORES DE RESPUESTA A NUEVOS ANTICOAGULANTES ORALES EN EL TRATAMIENTO DE LA FIBRILACIÓN AURICULAR NO VALVULAR

2019 to 2023 | Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Pablo Zubiaur

Ensayo clínico aleatorizado para evaluar la utilidad del genotipado de CYP2D6 para mejorar la eficacia y la seguridad del tramadol en el tratamiento del dolor postoperatorio agudo

Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Pablo Zubiaur

Identificación de polimorfismos en transportadores que influyen sobre la farmacocinética y la respuesta a metformina en voluntarios sanos y pacientes con diabetes mellitus tipo 2

Grant
Junta de Castilla y León (Madrid, ES)
Source: Self-asserted source
Pablo Zubiaur

Influencia de los polimorfismos de ABCB1 en el transporte de ibrutinib in vitro y su posible implicación en el tratamiento de la leucemia linfocítica crónica

Grant
Junta de Castilla y León (Madrid, ES)
Source: Self-asserted source
Pablo Zubiaur

Monitorización terapéutica y estudio farmacogenético de ibrutinib en pacientes con leucemia linfocítica crónica. Junta de Castilla y León

Grant
Junta de Castilla y León (Madrid, ES)
Source: Self-asserted source
Pablo Zubiaur

Proyecto iPHARMGx: Estudio colaborativo nacional para evaluar la efectividad y eficiencia de la implementación de biomarcadores farmacogenéticos mediante una estrategia de genotipado anticipado en el SNS

Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Pablo Zubiaur

Utilidad de la farmacogenética para mejorar la prescripción de estatinas en atención primaria y especializada: percepciones y formación de médicos prescriptores.

Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Pablo Zubiaur

Works (50 of 59)

Items per page:
Page 1 of 2

Impact of Genetic Variants on Pregabalin Pharmacokinetics and Safety

Pharmaceuticals
2025-01 | Journal article | Author
DOI: 10.3390/ph18020151
Contributors: Sofía Calleja Aznárez; Andrea Rodríguez-López; Dolores Ochoa; Sergio Luquero-Bueno; Marcos Navares-Gómez; Manuel Román Martínez; Gina Paola Mejía Abril; Samuel Martín-Vilchez; Francisco Abad-Santos; Pablo Zubiaur
Source: check_circle
Multidisciplinary Digital Publishing Institute

Impact of <i>STAT6</i> Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis

International Journal of Molecular Sciences
2024-03 | Journal article | Author
DOI: 10.3390/ijms25073685
Contributors: Paula Soria Chacartegui; Marcos Navares-Gómez; Francisca Molina-Jiménez; Emilio Jose Laserna-Mendieta; Laura Arias-González; Pedro Majano; Sergio Casabona Francés; Alfredo J Lucendo; Francisco Abad-Santos; Cecilio Santander Vaquero et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine

Pharmaceuticals
2024-01 | Journal article | Author
DOI: 10.3390/ph17010069
Contributors: Andrea Rodríguez-Lopez; Gina Paola Mejía Abril; Pablo Zubiaur; Sofía Calleja; Manuel Román; Francisco Abad-Santos; Dolores Ochoa
Source: check_circle
Multidisciplinary Digital Publishing Institute

Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride

Journal of Personalized Medicine
2023-10 | Journal article | Author
DOI: 10.3390/jpm13111566
Contributors: Gonzalo Villapalos García; Pablo Zubiaur; Cristina Marián-Revilla; Paula Soria-Chacartegui; Marcos Navares-Gómez; Gina Paola Mejía Abril; Andrea Rodríguez-Lopez; Eva González-Iglesias; Samuel Martín-Vílchez; Manuel Román et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide

International Journal of Molecular Sciences
2023-10 | Journal article | Author
DOI: 10.3390/ijms242015265
Contributors: Paula Soria-Chacartegui; Pablo Zubiaur; Dolores Ochoa; Marcos Navares-Gómez; Houwaida Abbes; Gonzalo Villapalos García; Alejandro de Miguel; Eva González-Iglesias; Andrea Rodríguez-Lopez; Gina Paola Mejía Abril et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Preemptive <i>TPMT</i> Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases

Journal of Personalized Medicine
2023-07 | Journal article | Author
DOI: 10.3390/jpm13081208
Contributors: Sarahí Valdez-Acosta; Pablo Zubiaur; Miguel Angel Casado; Jesús Novalbos Reina; Ana Casajús; Diana Campodónico; Itziar Oyagüez; Francisco Abad-Santos
Source: check_circle
Multidisciplinary Digital Publishing Institute

Genetic Variation in <i>CYP2D6</i> and <i>SLC22A1</i> Affects Amlodipine Pharmacokinetics and Safety

Pharmaceutics
2023-01 | Journal article | Author
DOI: 10.3390/pharmaceutics15020404
Contributors: Paula Soria-Chacartegui; Pablo Zubiaur; Dolores Ochoa; Gonzalo Villapalos García; Manuel Román; Miriam Matas; Laura Figueiredo-Tor; Gina Paola Mejía Abril; Sofía Calleja; Alejandro de Miguel et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

“Pharmacogenetics of siponimod: A systematic review” by Díaz-Villamarín et al. – Information is power

Biomedicine &amp; Pharmacotherapy
2023-01 | Journal article | Author
DOI: 10.1016/j.biopha.2022.114003
Part of ISSN: 0753-3322
Contributors: Pablo Zubiaur; Miriam Saiz-Rodríguez; Francisco Abad-Santos
Source: Self-asserted source
Pablo Zubiaur

Association Studies in Clinical Pharmacogenetics

Pharmaceutics
2022-12 | Journal article | Author
DOI: 10.3390/pharmaceutics15010113
Contributors: Pablo Zubiaur; Francisco Abad-Santos
Source: check_circle
Multidisciplinary Digital Publishing Institute

Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight

Metabolism
2022-12 | Journal article
DOI: 10.1016/j.metabol.2022.155335
Part of ISSN: 0026-0495
Contributors: Pablo Zubiaur; Vitor Ferreira; Cintia Folgueira; Maria Guillén; Pablo Zubiaur; Marcos Navares; Assel Sarsenbayeva; Pilar López-Larrubia; Jan W. Eriksson; Maria J. Pereira et al.
Source: Self-asserted source
Pablo Zubiaur

Use of pharmacogenetics for benzodiazepine prescription: state of the art and expectations

Pharmacogenomics
2022-12 | Journal article | Author
DOI: 10.2217/pgs-2022-0161
Part of ISSN: 1462-2416
Part of ISSN: 1744-8042
Contributors: Pablo Zubiaur; Francisco Abad-Santos
Source: Self-asserted source
Pablo Zubiaur

Dasatinib-induced spleen contraction leads to transient lymphocytosis

Blood Advances
2022-12-30 | Journal article
DOI: 10.1182/bloodadvances.2022009279
Part of ISSN: 2473-9529
Part of ISSN: 2473-9537
Contributors: Ana Marcos-Jiménez; Daniela Claudino Carvoeiro; Nora Ruef; Carlos Cuesta-Mateos; Emilia Roy Vallejo; Valle Gómez-García de Soria; Claudio Laganá; Lourdes Del Campo; Pablo Zubiaur; Gonzalo Villapalos García et al.
Source: Self-asserted source
Pablo Zubiaur

Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam

Biomedicine &amp; Pharmacotherapy
2022-11 | Journal article
DOI: 10.1016/j.biopha.2022.113747
Part of ISSN: 0753-3322
Contributors: Pablo Zubiaur; Pablo Zubiaur; Laura Figueiredo-Tor; Gonzalo Villapalos-García; Paula Soria-Chacartegui; Marcos Navares-Gómez; Jesús Novalbos; Miriam Matas; Sofía Calleja; Gina Mejía-Abril et al.
Source: Self-asserted source
Pablo Zubiaur

CYP2C18: the orphan in the CYP2C family

Pharmacogenomics
2022-11 | Journal article | Author
DOI: 10.2217/pgs-2022-0142
Part of ISSN: 1462-2416
Part of ISSN: 1744-8042
Contributors: Pablo Zubiaur; Andrea Gaedigk
Source: Self-asserted source
Pablo Zubiaur

Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity

Life Science Alliance
2022-10 | Journal article | Author
DOI: 10.26508/lsa.202201545
Part of ISSN: 2575-1077
Contributors: Gonzalo Villapalos García; Pablo Zubiaur; Rebeca Rivas-Durán; Pilar Campos-Norte; Cristina Arévalo-Román; Marta Fernández-Rico; Lucio García-Fraile Fraile; Paula Fernández-Campos; Paula Soria Chacartegui; Sara Fernández de Córdoba-Oñate et al.
Source: Self-asserted source
Pablo Zubiaur

Transmembrane protease serine 2 (<i>TMPRSS2</i>) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity

Life Science Alliance
2022-10 | Journal article
DOI: 10.26508/lsa.202201396
Part of ISSN: 2575-1077
Contributors: Pablo Zubiaur
Source: Self-asserted source
Pablo Zubiaur

Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline

Pharmaceutics
2022-09-21 | Journal article | Author
DOI: 10.3390/pharmaceutics14102001
Part of ISSN: 1999-4923
Contributors: Pablo Zubiaur; Miriam Matas; Samuel Martín-Vílchez; Paula Soria Chacartegui; Gonzalo Villapalos García; Laura Figueiredo-Tor; Sofía Calleja Aznárez; Marcos Navares-Gómez; Alejandro de Miguel; Jesús Novalbos et al.
Source: Self-asserted source
Pablo Zubiaur

CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride

Clinical and Translational Science
2022-09-06 | Journal article | Author
DOI: 10.1111/cts.13386
Part of ISSN: 1752-8054
Part of ISSN: 1752-8062
Contributors: Diana Campodónico; Pablo Zubiaur; Paula Soria Chacartegui; Ana Casajus ; Gonzalo Villapalos García; Marcos Navares Gómez; Antia Gomez-Fernandez; Raúl Parra-Garcés; Gina Paola Mejía Abril; Manuel Román Martínez et al.
Source: Self-asserted source
Pablo Zubiaur

Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg

Cancer Chemotherapy and Pharmacology
2022-08 | Journal article
DOI: 10.1007/s00280-022-04454-y
Part of ISSN: 0344-5704
Part of ISSN: 1432-0843
Contributors: Pablo Zubiaur
Source: Self-asserted source
Pablo Zubiaur
grade
Preferred source (of 2)‎

Association between CES1 rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysis

Frontiers in Cardiovascular Medicine
2022-08-04 | Journal article
DOI: 10.3389/fcvm.2022.959916
Part of ISSN: 2297-055X
Contributors: Pablo Zubiaur; Haobo Li; Zhu Zhang; Haoyi Weng; Yuting Qiu; Pablo Zubiaur; Yu Zhang; Guohui Fan; Peiran Yang; Anna-Leena Vuorinen et al.
Source: Self-asserted source
Pablo Zubiaur

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects

Journal of Personalized Medicine
2022-05 | Journal article | Author
DOI: 10.3390/jpm12050788
Contributors: María C Ovejero-Benito; Dolores Ochoa; Teresa Enrique-Benedito; Miriam del Peso-Casado; Pablo Zubiaur; Marcos Navares; Manuel Román; Francisco Abad-Santos
Source: check_circle
Multidisciplinary Digital Publishing Institute

Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers

Advances in Therapy
2022-04 | Journal article
DOI: 10.1007/s12325-022-02067-8
Part of ISSN: 0741-238X
Part of ISSN: 1865-8652
Contributors: Pablo Zubiaur
Source: Self-asserted source
Pablo Zubiaur

Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

Pharmaceutics
2022-03 | Journal article | Author
DOI: 10.3390/pharmaceutics14030559
Contributors: Álvaro Pinto Merino; JORGE LABRADOR; Pablo Zubiaur; Raquel Alcaraz; Maria Jose Herrero; Pau Montesinos; Francisco Abad-Santos; Miriam Saiz Rodríguez
Source: check_circle
Multidisciplinary Digital Publishing Institute

Patients&rsquo; Perceptions of Pharmacogenetic Testing and Access to Their Results: State of the Art in Spain and Systematic Review

Journal of Personalized Medicine
2022-02 | Journal article | Author
DOI: 10.3390/jpm12020270
Contributors: Pablo Zubiaur; David Nicolás Prósper-Cuesta; Jesús Novalbos; Gina Paola Mejía Abril; Marcos Navares-Gómez; Gonzalo Villapalos García; Paula Soria-Chacartegui; Francisco Abad-Santos
Source: check_circle
Multidisciplinary Digital Publishing Institute

A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis

Pharmaceuticals
2022-01 | Journal article | Author
DOI: 10.3390/ph15010078
Contributors: Jaime Monserrat Villatoro; Gina Mejía-Abril; Lucía Díaz García; Pablo Zubiaur; María Jiménez-González; Guillermo Fernandez Jimenez; Inés Cancio; José Ramón Arribas; Carmen Suarez Fernández; Jesus Mingorance et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics

Biomedicine and Pharmacotherapy
2021 | Journal article
DOI: 10.1016/j.biopha.2021.112083
EID:

2-s2.0-85113339852

Part of ISSN: 19506007 07533322
Contributors: Zubiaur, P.; del Peso-Casado, M.; Ochoa, D.; Enrique-Benedito, T.; Mejía-Abril, G.; Navares, M.; Villapalos-García, G.; Román, M.; Abad-Santos, F.; Ovejero-Benito, M.C.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Infectious Diseases and Therapy
2021 | Journal article
DOI: 10.1007/s40121-020-00373-8
EID:

2-s2.0-85097137129

Part of ISSN: 21936382 21938229
Contributors: Ruiz-Antorán, B.; Sancho-López, A.; Torres, F.; Moreno-Torres, V.; de Pablo-López, I.; García-López, P.; Abad-Santos, F.; Rosso-Fernández, C.M.; Aldea-Perona, A.; Montané, E. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism

Frontiers in Pharmacology
2021 | Journal article
DOI: 10.3389/fphar.2021.660639
EID:

2-s2.0-85106041112

Part of ISSN: 16639812
Contributors: Mejía-Abril, G.; Zubiaur, P.; Navares-Gómez, M.; Villapalos-García, G.; Román, M.; Ochoa, D.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling

Clinical Pharmacokinetics
2021 | Journal article
DOI: 10.1007/s40262-020-00941-8
EID:

2-s2.0-85091088127

Part of ISSN: 11791926 03125963
Contributors: Zubiaur, P.; Kneller, L.A.; Ochoa, D.; Mejía, G.; Saiz-Rodríguez, M.; Borobia, A.M.; Koller, D.; García, I.G.; Navares-Gómez, M.; Hempel, G. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

Frontiers in Pharmacology
2021 | Journal article
DOI: 10.3389/fphar.2021.711940
EID:

2-s2.0-85111445248

Part of ISSN: 16639812
Contributors: Soria-Chacartegui, P.; Villapalos-García, G.; Zubiaur, P.; Abad-Santos, F.; Koller, D.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

HCP5 rs2395029 is a rapid and inexpensive alternative to HLA-B∗ 57:01 genotyping to predict abacavir hypersensitivity reaction in Spain

Pharmacogenetics and Genomics
2021 | Journal article
DOI: 10.1097/FPC.0000000000000421
EID:

2-s2.0-85102603098

Part of ISSN: 17446880 17446872
Contributors: Zubiaur, P.; Saiz-RodrÃ-Guez, M.; Villapalos-GarcÃ-A, G.; Navares-GÃmez, M.; Koller, D.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study

BMC Medicine
2021 | Journal article
DOI: 10.1186/s12916-021-01992-9
EID:

2-s2.0-85105840340

Part of ISSN: 17417015
Contributors: de Abajo, F.J.; Rodríguez-Miguel, A.; Rodríguez-Martín, S.; Lerma, V.; García-Lledó, A.; de Abajo, F.J.; Rodríguez-Miguel, A.; Rodríguez-Martín, S.; Lerma, V.; García-Lledó, A. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers

Biomedicine and Pharmacotherapy
2021 | Journal article
DOI: 10.1016/j.biopha.2020.111087
EID:

2-s2.0-85097719105

Part of ISSN: 19506007 07533322
Contributors: Zubiaur, P.; Soria-Chacartegui, P.; Koller, D.; Navares-Gómez, M.; Ochoa, D.; Almenara, S.; Saiz-Rodríguez, M.; Mejía-Abril, G.; Villapalos-García, G.; Román, M. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach

Clinical Pharmacokinetics
2021 | Journal article
DOI: 10.1007/s40262-021-01041-x
EID:

2-s2.0-85107873413

Part of ISSN: 11791926 03125963
Contributors: Kneller, L.A.; Zubiaur, P.; Koller, D.; Abad-Santos, F.; Hempel, G.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics

Advances in Therapy
2021 | Journal article
DOI: 10.1007/s12325-020-01566-w
EID:

2-s2.0-85097133625

Part of ISSN: 18658652 0741238X
Contributors: Koller, D.; Almenara, S.; Mejía, G.; Saiz-Rodríguez, M.; Zubiaur, P.; Román, M.; Ochoa, D.; Navares-Gómez, M.; Santos-Molina, E.; Pintos-Sánchez, E. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

PriME-PGX: La Princesa university hospital multidisciplinary initiative for the implementation of pharmacogenetics

Journal of Clinical Medicine
2021 | Journal article
DOI: 10.3390/jcm10173772
EID:

2-s2.0-85113322119

Part of ISSN: 20770383
Contributors: Zubiaur, P.; Mejía-Abril, G.; Navares-Gómez, M.; Villapalos-García, G.; Soria-Chacartegui, P.; Saiz-Rodríguez, M.; Ochoa, D.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

Human Psychopharmacology
2021 | Journal article
DOI: 10.1002/hup.2761
EID:

2-s2.0-85091682063

Part of ISSN: 10991077 08856222
Contributors: Koller, D.; Almenara, S.; Mejía, G.; Saiz-Rodríguez, M.; Zubiaur, P.; Román, M.; Ochoa, D.; Wojnicz, A.; Martín, S.; Romero-Palacián, D. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Slco1b1 phenotype and cyp3a5 polymorphism significantly affect atorvastatin bioavailability

Journal of Personalized Medicine
2021 | Journal article
DOI: 10.3390/jpm11030204
EID:

2-s2.0-85103078819

Part of ISSN: 20754426
Contributors: Zubiaur, P.; Benedicto, M.D.; Villapalos-García, G.; Navares-Gómez, M.; Mejía-Abril, G.; Román, M.; Martín-Vílchez, S.; Ochoa, D.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study

Pharmaceutics
2021-11 | Journal article | Author
DOI: 10.3390/pharmaceutics13122036
Contributors: Paula Soria Chacartegui; Gonzalo Villapalos García; Luis A. López-Fernández; Marcos Navares Gómez; Gina Paola Mejía Abril; Francisco Abad-Santos; Pablo Zubiaur
Source: check_circle
Multidisciplinary Digital Publishing Institute

Variants in <i>COMT</i>, <i>CYP3A5</i>, <i>CYP2B6,</i> and <i>ABCG2</i> Alter Quetiapine Pharmacokinetics

Pharmaceutics
2021-09 | Journal article | Author
DOI: 10.3390/pharmaceutics13101573
Contributors: Pablo Zubiaur; Paula Fernández-Campos; Marcos Navares Gómez; Paula Soria Chacartegui; Gonzalo Villapalos García; Manuel Román; Gina Paola Mejía Abril; Dolores Ochoa; Francisco Abad-Santos
Source: check_circle
Multidisciplinary Digital Publishing Institute

Author’s Response to: ‘Letter to the Editor in Response to: “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”’

Advances in Therapy
2020 | Journal article
DOI: 10.1007/s12325-019-01196-x
EID:

2-s2.0-85077154799

Part of ISSN: 18658652 0741238X
Contributors: Zubiaur, P.; Saiz-Rodríguez, M.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran

Advances in Therapy
2020 | Journal article
DOI: 10.1007/s12325-020-01414-x
EID:

2-s2.0-85086791425

Part of ISSN: 18658652 0741238X
Contributors: Zubiaur, P.; Saiz-Rodríguez, M.; Ochoa, D.; Navares-Gómez, M.; Mejía, G.; Román, M.; Koller, D.; Soria-Chacartegui, P.; Almenara, S.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the pharmacokinetic parameters of 10 CYP3A substrates

Biomedicines
2020 | Journal article
DOI: 10.3390/biomedicines8040094
EID:

2-s2.0-85083726855

Part of ISSN: 22279059
Contributors: Saiz-Rodríguez, M.; Almenara, S.; Navares-Gómez, M.; Ochoa, D.; Román, M.; Zubiaur, P.; Koller, D.; Santos, M.; Mejía, G.; Borobia, A.M. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring

Talanta
2020 | Journal article
DOI: 10.1016/j.talanta.2019.120450
EID:

2-s2.0-85073758115

Part of ISSN: 00399140
Contributors: Koller, D.; Vaitsekhovich, V.; Mba, C.; Steegmann, J.L.; Zubiaur, P.; Abad-Santos, F.; Wojnicz, A.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers

Basic and Clinical Pharmacology and Toxicology
2020 | Journal article
DOI: 10.1111/bcpt.13323
EID:

2-s2.0-85073925359

Part of ISSN: 17427843 17427835
Contributors: Koller, D.; Belmonte, C.; Saiz-Rodríguez, M.; Zubiaur, P.; Román, M.; Ochoa, D.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19)

Clinical and Translational Science
2020 | Journal article
DOI: 10.1111/cts.12866
EID:

2-s2.0-85090924382

Part of ISSN: 17528062 17528054
Contributors: Zubiaur, P.; Koller, D.; Saiz-Rodríguez, M.; Navares-Gómez, M.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers

Pharmacogenomics Journal
2020 | Journal article
DOI: 10.1038/s41397-019-0103-3
EID:

2-s2.0-85074612649

Part of ISSN: 14731150 1470269X
Contributors: Zubiaur, P.; Saiz-Rodríguez, M.; Ochoa, D.; Belmonte, C.; Román, M.; Mejía, G.; Martín-Vilchez, S.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics

Pharmacogenomics
2020 | Journal article
DOI: 10.2217/pgs-2020-0026
EID:

2-s2.0-85088177024

Part of ISSN: 17448042 14622416
Contributors: Saiz-Rodríguez, M.; Ochoa, D.; Román, M.; Zubiaur, P.; Koller, D.; Mejía, G.; Abad-Santos, F.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial

British Journal of Clinical Pharmacology
2020 | Journal article
DOI: 10.1111/bcp.14300
EID:

2-s2.0-85084129419

Part of ISSN: 13652125 03065251
Contributors: Koller, D.; Saiz-Rodríguez, M.; Zubiaur, P.; Ochoa, D.; Almenara, S.; Román, M.; Romero-Palacián, D.; de Miguel-Cáceres, A.; Martín, S.; Navares-Gómez, M. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

The Lancet
2020 | Journal article
DOI: 10.1016/S0140-6736(20)31030-8
EID:

2-s2.0-85085205357

Part of ISSN: 1474547X 01406736
Contributors: de Abajo, F.J.; Rodríguez-Martín, S.; Lerma, V.; Mejía-Abril, G.; Aguilar, M.; García-Luque, A.; Laredo, L.; Laosa, O.; Centeno-Soto, G.A.; Ángeles Gálvez, M. et al.
Source: Self-asserted source
Pablo Zubiaur via Scopus - Elsevier
Items per page:
Page 1 of 2

Peer review (10 reviews for 5 publications/grants)

Review activity for BMJ open. (2)
Review activity for Cancer chemotherapy and pharmacology. (1)
Review activity for Pharmaceuticals. (2)
Review activity for Pharmaceutics. (1)
Review activity for Pharmacological Reports. (4)
How many people are using ORCID?